3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate

C98H88Cl3N31O8S — CID 158585047

IUPAC3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate
SMILESCCOC(=O)c1ccc(CNC(=O)c2nc(-c3cc(Cl)c4[nH]ncc4c3)c(-c3cn(C)cn3)nc2N)cc1.Cc1ccn(-c2nc(N)c(C(=O)NCN3CCOCC3)nc2-c2cc(Cl)c3nc[nH]c3c2)n1.Cc1cnc(-c2nc(N)c(C(=O)Nc3ccc(C#N)cc3)nc2-c2cc(C)c3ncccc3c2)s1.Cn1ccc(-c2nc(N)c(C(=O)NCN3CCCCC3=O)nc2-c2cc(Cl)c3ncccc3c2)c1
InChIInChI=1S/C26H23ClN8O3.C26H19N7OS.C25H24ClN7O2.C21H22ClN9O2/c1-3-38-26(37)15-6-4-14(5-7-15)10-29-25(36)23-24(28)33-22(19-12-35(2)13-30-19)21(32-23)16-8-17-11-31-34-20(17)18(27)9-16;1-14-10-18(11-17-4-3-9-29-20(14)17)21-22(26-30-13-15(2)35-26)33-24(28)23(32-21)25(34)31-19-7-5-16(12-27)6-8-19;1-32-10-7-16(13-32)21-22(17-11-15-5-4-8-28-20(15)18(26)12-17)30-23(24(27)31-21)25(35)29-14-33-9-3-2-6-19(33)34;1-12-2-3-31(29-12)20-16(13-8-14(22)17-15(9-13)24-10-25-17)27-18(19(23)28-20)21(32)26-11-30-4-6-33-7-5-30/h4-9,11-13H,3,10H2,1-2H3,(H2,28,33)(H,29,36)(H,31,34);3-11,13H,1-2H3,(H2,28,33)(H,31,34);4-5,7-8,10-13H,2-3,6,9,14H2,1H3,(H2,27,31)(H,29,35);2-3,8-10H,4-7,11H2,1H3,(H2,23,28)(H,24,25)(H,26,32)
InChIKeyHTSLFMKTVPXUJF-UHFFFAOYSA-N
MW1966.42 g/mol
LogP14.30
Rot. Bonds21

About 3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate

3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate (PubChem CID 158585047) has the molecular formula C98H88Cl3N31O8S and a molecular weight of 1966.42 g/mol. Its IUPAC name is 3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate.

Molecular Properties

Compound Name3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate
PubChem CID158585047
Molecular FormulaC98H88Cl3N31O8S
Molecular Weight1966.42 g/mol
Exact Mass1963.62
IUPAC Name3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate
SMILESCCOC(=O)c1ccc(CNC(=O)c2nc(-c3cc(Cl)c4[nH]ncc4c3)c(-c3cn(C)cn3)nc2N)cc1.Cc1ccn(-c2nc(N)c(C(=O)NCN3CCOCC3)nc2-c2cc(Cl)c3nc[nH]c3c2)n1.Cc1cnc(-c2nc(N)c(C(=O)Nc3ccc(C#N)cc3)nc2-c2cc(C)c3ncccc3c2)s1.Cn1ccc(-c2nc(N)c(C(=O)NCN3CCCCC3=O)nc2-c2cc(Cl)c3ncccc3c2)c1
InChIInChI=1S/C26H23ClN8O3.C26H19N7OS.C25H24ClN7O2.C21H22ClN9O2/c1-3-38-26(37)15-6-4-14(5-7-15)10-29-25(36)23-24(28)33-22(19-12-35(2)13-30-19)21(32-23)16-8-17-11-31-34-20(17)18(27)9-16;1-14-10-18(11-17-4-3-9-29-20(14)17)21-22(26-30-13-15(2)35-26)33-24(28)23(32-21)25(34)31-19-7-5-16(12-27)6-8-19;1-32-10-7-16(13-32)21-22(17-11-15-5-4-8-28-20(15)18(26)12-17)30-23(24(27)31-21)25(35)29-14-33-9-3-2-6-19(33)34;1-12-2-3-31(29-12)20-16(13-8-14(22)17-15(9-13)24-10-25-17)27-18(19(23)28-20)21(32)26-11-30-4-6-33-7-5-30/h4-9,11-13H,3,10H2,1-2H3,(H2,28,33)(H,29,36)(H,31,34);3-11,13H,1-2H3,(H2,28,33)(H,31,34);4-5,7-8,10-13H,2-3,6,9,14H2,1H3,(H2,27,31)(H,29,35);2-3,8-10H,4-7,11H2,1H3,(H2,23,28)(H,24,25)(H,26,32)
InChIKeyHTSLFMKTVPXUJF-UHFFFAOYSA-N
XLogP14.30
TPSA543.07 Ų
H-Bond Donors10
H-Bond Acceptors33
Rotatable Bonds21
Heavy Atoms141
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001966.42
LogP ≤ 514.30
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1033

Analyze 3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

6-[5-amino-6-chloro-3-(1-methylimidazol-4-yl)pyrazin-2-yl]-8-chloro-1H-quinolin-2-one;6-[5-amino-3-(3-methylpyrazol-1-yl)-6-(trifluoromethyl)pyrazin-2-yl]-1H-quinolin-4-one;5-(7-chloro-3H-benzimidazol-5-yl)-6-(3-methylpyrazol-1-yl)-3-(trifluoromethoxy)pyrazin-2-amine;3-chloro-5-(8-chloroquinolin-6-yl)-6-(5-methyl-1,3-thiazol-2-yl)pyrazin-2-amine;3-fluoro-6-(5-methylfuran-2-yl)-5-quinolin-6-ylpyrazin-2-amine
CID 157085973
1-[5-acetyl-6-amino-3-(8-chloroquinolin-6-yl)pyrazin-2-yl]pyridin-2-one;[3-amino-6-(4-chloro-1,3-benzothiazol-6-yl)-5-phenylpyrazin-2-yl]-cyclopentylmethanone;6-[5-amino-3-(1-methylpyrazol-3-yl)-6-[2-(1-methylpyrrol-2-yl)ethyl]pyrazin-2-yl]-8-methyl-2H-isoquinolin-1-one;5-(7-chloro-3H-benzimidazol-5-yl)-6-(5-methyl-1,2-thiazol-3-yl)-3-N-(oxan-4-ylmethyl)pyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N,3-N-dimethyl-6-phenylpyrazine-2,3-diamine
CID 158976785
N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylimidazol-4-yl)pyrazin-2-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[3-amino-6-(8-chloroquinolin-6-yl)-5-(2-oxo-1-pyridinyl)pyrazin-2-yl]-2-(3-hydroxypyrrolidin-1-yl)acetamide;N-[3-amino-5-(5-methyl-1,3-thiazol-2-yl)-6-(1-oxo-2H-isoquinolin-6-yl)pyrazin-2-yl]-4-(methylamino)benzamide;ethyl 4-[2-[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylpyrazol-3-yl)pyrazin-2-yl]amino]-2-oxoethyl]benzoate
CID 160212040
N-[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-phenylpyrazin-2-yl]acetamide;N-[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-phenylpyrazin-2-yl]-N-methylpropanamide;1-[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-phenylpyrazin-2-yl]-2-(3-methylpyrrol-1-yl)ethanone;1-[2-[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-phenylpyrazin-2-yl]-2-oxoethyl]pyridin-2-one;ethyl 4-[2-[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-phenylpyrazin-2-yl]-2-oxoethyl]benzoate
CID 161623138
3-amino-5-(1H-benzimidazol-2-yl)-6-(7-chloro-1H-indazol-5-yl)pyrazine-2-carbonitrile;3-amino-5-(1,3-benzothiazol-2-yl)-6-(7-chloro-1H-indazol-5-yl)pyrazine-2-carbonitrile;3-amino-5-(1,3-benzoxazol-2-yl)-6-(7-chloro-1H-indazol-5-yl)pyrazine-2-carbonitrile;3-amino-6-(7-chloro-1H-indazol-5-yl)-5-indazol-2-ylpyrazine-2-carbonitrile;5-(8-chloroquinolin-6-yl)-3-methyl-6-(1-methylpyrazol-3-yl)pyrazin-2-amine
CID 161856412
3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrazol-3-yl)-N-[(3-oxocyclohexyl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-5-(3-methylpyrazol-1-yl)-6-quinolin-6-ylpyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylpyrazol-3-yl)pyrazine-2-carbonyl]amino]methyl]benzoate
CID 162259921
4-(5-tert-butyl-7,8-dihydronaphthalen-2-yl)-1-methylpyrazole;8-tert-butylimidazo[1,2-a]pyridine-2-carboxylic acid;4-tert-butyl-1H-indazole;4-tert-butyl-1H-indole;5-(8-tert-butylisoquinolin-3-yl)-2-methyl-1,3-thiazole;5-tert-butyl-3-methyl-2-(1-methylpyrazol-4-yl)-3,4-dihydro-1H-isoquinoline;5-tert-butyl-2-(1-methylpyrazol-4-yl)-3,4-dihydro-1H-isoquinoline;5-tert-butyl-2-(1-methylpyrazol-4-yl)-1,4-dihydroisoquinolin-3-one;4-tert-butyl-2-pyridin-3-yl-1H-benzimidazole;methyl 4-tert-butyl-1H-indole-6-carboxylate
CID 164971106

Frequently Asked Questions

What is the IUPAC name of 3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate?
The IUPAC name of 3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate (CID 158585047) is 3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate.
What is the SMILES notation for 3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate?
The canonical SMILES for 3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate is CCOC(=O)c1ccc(CNC(=O)c2nc(-c3cc(Cl)c4[nH]ncc4c3)c(-c3cn(C)cn3)nc2N)cc1.Cc1ccn(-c2nc(N)c(C(=O)NCN3CCOCC3)nc2-c2cc(Cl)c3nc[nH]c3c2)n1.Cc1cnc(-c2nc(N)c(C(=O)Nc3ccc(C#N)cc3)nc2-c2cc(C)c3ncccc3c2)s1.Cn1ccc(-c2nc(N)c(C(=O)NCN3CCCCC3=O)nc2-c2cc(Cl)c3ncccc3c2)c1.
What is the InChIKey of 3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate?
The InChIKey is HTSLFMKTVPXUJF-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H23ClN8O3.C26H19N7OS.C25H24ClN7O2.C21H22ClN9O2/c1-3-38-26(37)15-6-4-14(5-7-15)10-29-25(36)23-24(28)33-22(19-12-35(2)13-30-19)21(32-23)16-8-17-11-31-34-20(17)18(27)9-16;1-14-10-18(11-17-4-3-9-29-20(14)17)21-22(26-30-13-15(2)35-26)33-24(28)23(32-21)25(34)31-19-7-5-16(12-27)6-8-19;1-32-10-7-16(13-32)21-22(17-11-15-5-4-8-28-20(15)18(26)12-17)30-23(24(27)31-21)25(35)29-14-33-9-3-2-6-19(33)34;1-12-2-3-31(29-12)20-16(13-8-14(22)17-15(9-13)24-10-25-17)27-18(19(23)28-20)21(32)26-11-30-4-6-33-7-5-30/h4-9,11-13H,3,10H2,1-2H3,(H2,28,33)(H,29,36)(H,31,34);3-11,13H,1-2H3,(H2,28,33)(H,31,34);4-5,7-8,10-13H,2-3,6,9,14H2,1H3,(H2,27,31)(H,29,35);2-3,8-10H,4-7,11H2,1H3,(H2,23,28)(H,24,25)(H,26,32).
What are the key properties of 3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate?
3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate has a molecular weight of 1966.42 g/mol, XLogP of 14.30, 21 rotatable bonds, 10 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 3-amino-6-(7-chloro-3H-benzimidazol-5-yl)-5-(3-methylpyrazol-1-yl)-N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;3-amino-6-(8-chloroquinolin-6-yl)-5-(1-methylpyrrol-3-yl)-N-[(2-oxopiperidin-1-yl)methyl]pyrazine-2-carboxamide;3-amino-N-(4-cyanophenyl)-6-(8-methylquinolin-6-yl)-5-(5-methyl-1,3-thiazol-2-yl)pyrazine-2-carboxamide;ethyl 4-[[[3-amino-6-(7-chloro-1H-indazol-5-yl)-5-(1-methylimidazol-4-yl)pyrazine-2-carbonyl]amino]methyl]benzoate is sourced from PubChem (CID 158585047), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).